A patient with cough, fever, and night sweats. A video consultation. An urgent referral. A diagnosis of HIV and Pneumocystis pneumonia. What this case taught me about what telemedicine can — and cannot — do.
▶ Watch the full video on YouTube
Infectious Diseases in Focus →Telemedicine has transformed access to medical care. For patients in remote areas, for those who cannot easily leave work or home, for people who need specialist opinions that are simply not available locally — video consultations have opened doors that were previously closed.
But telemedicine is not perfect for every situation. And in infectious disease medicine — a specialty where the physical examination, the complete clinical history, and the right diagnostic tests can be the difference between a timely diagnosis and a catastrophic delay — understanding its limits matters enormously.
I want to share a real case from my own practice. I have anonymized all identifying details. The purpose is not to frighten anyone away from using telemedicine — it is to help both patients and clinicians use it more wisely.
Some time ago, I conducted a video consultation with a patient who presented with a triad of symptoms: persistent cough, fever, and night sweats. These three symptoms together constitute a classic warning pattern in infectious disease — they can indicate tuberculosis, lymphoma, other serious infections, or, as in this case, an opportunistic infection in the context of immunosuppression.
Based on the history and the symptom pattern, I suspected tuberculosis and referred him urgently to the hospital for evaluation, including chest imaging and laboratory testing.
A few weeks later, he contacted me again. He had been hospitalized. The diagnosis was HIV disease — with a CD4 count low enough to classify him as having AIDS — complicated by Pneumocystis pneumonia, known as PCP. PCP is caused by Pneumocystis jirovecii, a fungal pathogen that causes life-threatening pneumonia almost exclusively in people with severely compromised immune systems.
But the case left me thinking carefully about what the video consultation could and could not assess — and what the implications are for how telemedicine should be used in infectious disease practice.
The benefits of telemedicine are real and should be acknowledged clearly. For many patients and many clinical scenarios, it represents a meaningful improvement over the alternative of no specialist access at all.
Geographic access: A patient in a rural or underserved area can reach an infectious disease specialist via video who would otherwise require hours of travel, time off work, and significant expense. This access has direct health consequences — earlier specialist involvement, earlier appropriate diagnosis and treatment.
Infection risk reduction: This matters especially in infectious disease. Immunocompromised patients — those living with HIV, those on immunosuppressive medications, those receiving chemotherapy — should ideally not sit in waiting rooms alongside patients with active respiratory infections. Telemedicine removes this exposure entirely.
Follow-up efficiency: For stable, established patients with known diagnoses, telemedicine works very well. HIV monitoring visits, medication refills and reviews, follow-up after a completed antibiotic course for a simple infection — these are all appropriate and effective uses of video consultation.
Continuity during high-activity periods: During periods of high infectious disease activity, telemedicine allows care to continue safely for patients with stable conditions while preserving in-person capacity for those who truly need it.
The limitations are equally real — and in infectious disease medicine, they can have serious consequences.
This is the most fundamental constraint. In a video consultation, I cannot listen to your lungs with a stethoscope. I cannot measure your oxygen saturation. I cannot assess your respiratory effort — how hard you are working to breathe, whether you are using accessory muscles, whether your breathing is labored in ways that do not always translate through a camera. I cannot palpate lymph nodes, assess skin findings up close, or perform the components of a physical examination that have been foundational to clinical medicine for centuries.
In my patient's case, the severity of the lung infection — how compromised his respiratory function actually was — was not fully assessable through the video call alone. The referral was urgent, but I could not quantify the urgency with the precision that an in-person examination would have provided.
People with weakened immune systems — from HIV, from medications, from cancer treatment — can deteriorate faster and more unpredictably than immunocompetent patients. The clinical signs that herald serious deterioration may be subtler and may require in-person assessment to detect reliably. This population, paradoxically the one that most benefits from avoiding waiting rooms, is also the one for whom telemedicine diagnostic limitations carry the highest risk.
In infectious disease medicine, the clinical history is everything. Risk factors — sexual history, substance use, travel, occupational exposures, contacts with known cases — are often essential to arriving at the correct diagnosis. Some patients are less comfortable discussing these topics during a video call, particularly if they are at home in a shared space where others might hear the conversation. An incomplete history leads to an incomplete differential diagnosis — and an incomplete differential diagnosis can mean a delayed or missed diagnosis.
For any of these presentations, the appropriate response is in-person evaluation — with your primary care physician, with a specialist, or at an emergency department depending on the severity and urgency of your symptoms.
Technology is a tool. A powerful one — but a tool. It should support good clinical judgment, not replace it. A video consultation that leads to prompt in-person evaluation, as in my patient's case, can be the right clinical decision. A video consultation that provides false reassurance — because the severity of the illness simply cannot be assessed remotely — is a clinical failure, regardless of how well-intentioned the consultation was.
For patients: use telemedicine for what it does well, and recognize the warning signs that mean you need to be seen in person. For clinicians: explain the limitations of online care clearly, ask specifically about warning signs, and refer promptly when the clinical picture is unclear or concerning.
Telemedicine is convenient. It expands access. In the right circumstances, it saves lives. It is not perfect for every situation — and knowing the difference is what good medicine looks like.